Keyphrases
Indonesia
100%
Surabaya
52%
Meta-analysis
37%
Hepatitis B Virus
30%
Systematic Meta-analysis
28%
Hepatitis C Virus
27%
COVID-19
27%
Indonesian
24%
Gene Polymorphism
19%
General Hospital
18%
Rattus Norvegicus
18%
Genotype
17%
Blood Donors
15%
Traumatic Brain Injury
15%
Ethanol Extract
15%
Inflammation
14%
Wistar Rats
13%
Oxidative Stress
12%
Malondialdehyde
12%
Type 1 Diabetes Mellitus (T1DM)
11%
Treatment Group
11%
Pregnant Women
11%
Indonesian Patients
11%
East Java Indonesia
10%
Rat Model
10%
Preterm Infants
10%
COVID-19 Pandemic
10%
Hepatitis C Virus Genotypes
9%
GB Virus C (GBV-C)
9%
Tertiary Hospital
9%
AIDS/HIV
9%
Hyperbilirubinemia
9%
Pregnant Rats
9%
Risk Factors
9%
Neonatal Sepsis
9%
Obese Adolescents
9%
Interleukin-6
9%
Lipopolysaccharide
9%
Quantitative PCR
9%
Neonate
9%
Sepsis
9%
Hepatitis C Virus Infection
8%
Odds Ratio
8%
Hepcidin Levels
8%
Hyperbaric Oxygen Therapy
8%
Hepatocellular Carcinoma
8%
Hepcidin
8%
Confidence Interval
8%
F2-isoprostanes
8%
Chronic Liver Disease
8%
Virus
7%
HIV Patients
7%
Human Immunodeficiency Virus Type 1 (HIV-1)
7%
High-intensity Interval Training
7%
Prevalence Distribution
7%
Preterm Neonates
7%
Advanced Liver Disease
7%
Acute Coronary Syndrome
7%
Polymorphism
7%
Hepatitis B Surface Antigen (HBsAg)
7%
HHV-8
7%
NF-B
7%
Wet Cupping Therapy
7%
Latency
7%
Indonesian children
7%
Hyperbaric Oxygen
7%
Patent Ductus Arteriosus
7%
Bali Indonesia
7%
Solanum betaceum
7%
Rotavirus Infection
7%
Cigarette Smoking
7%
MRNA Expression
7%
Lipopolysaccharide-induced
7%
Serum Iron
7%
Hamp1
7%
Blood Glucose
6%
No Significant Difference
6%
5′-untranslated Region (5′-UTR)
6%
Children with Type 1 Diabetes
6%
Adiponectin
6%
Single nucleotide Polymorphism
6%
Parenteral nutrition
6%
Leaf Extract
6%
East Java
6%
Chronic Constriction Injury
6%
Hepatitis C Virus Subtype
6%
Antiretroviral Therapy
6%
Blood Pressure
6%
Regency
6%
Enzyme-linked Immunosorbent Assay (ELISA)
6%
Gestational Age
6%
Positive Control
6%
Birth Weight
6%
Endothelial Nitric Oxide Synthase (eNOS)
6%
Anti-hepatitis C Virus
6%
Genotype Distribution
5%
High Risk
5%
Sedentary Behavior
5%
VO2max
5%
Negative Control
5%
Pharmacology, Toxicology and Pharmaceutical Science
Hepatitis C Virus
24%
Prevalence
22%
Hepatitis B Virus
21%
Diseases
19%
Rattus norvegicus
15%
Prematurity
15%
Wistar Rat
15%
Infection
14%
Traumatic Brain Injury
14%
Coronavirinae
13%
Treatment Group
12%
Malonaldehyde
12%
HIV
11%
Rat Model
10%
Inflammation
10%
Interleukin 6
10%
Hemodialysis
9%
Hyperbilirubinemia
9%
Tumor Necrosis Factor
9%
Bilirubin
9%
Liver Cell Carcinoma
8%
Cytokine
8%
Isoprostane Derivative
8%
Lycopersicon
8%
Hepatitis G Virus
8%
Liver Disease
7%
Human Herpesvirus 8
7%
Mouse Model
7%
Cupping Therapy
7%
Mus musculus
7%
Cigarette Smoke
6%
Chronic Constriction Injury
6%
Enzyme-Linked Immunosorbent Assay
6%
Hepatitis C
6%
Alzheimer's Disease
6%
Hepatitis B
6%
Rotavirus
6%
Neuropathic Pain
6%
Streptozotocin
5%
Brain Derived Neurotrophic Factor
5%
Cross-Sectional Study
5%
Diabetes Mellitus
5%
SARS Coronavirus
5%
Antioxidant
5%
Endothelial Dysfunction
5%
Chronic Liver Disease
5%
Biological Marker
5%
Chronic Kidney Failure
5%
Medicine and Dentistry
Systematic Review
23%
Prematurity
22%
Meta-Analysis
19%
Cross Sectional Study
17%
COVID-19
14%
Pediatrics
12%
Infection
12%
Traumatic Brain Injury
12%
Neonatal Infant
11%
Human Immunodeficiency Virus
10%
Hepatitis B Virus
9%
Low Birth Weight
9%
Neonatal Sepsis
9%
Prevalence
9%
Parenteral Nutrition
8%
Hyperbilirubinemia
8%
Neurosurgery
7%
Neonatal Intensive Care Unit
7%
Hemodynamic
7%
Neonate
7%
Human Herpesvirus 8
7%
Insulin Dependent Diabetes Mellitus
7%
Lipopolysaccharide
7%
Human Milk
7%
Sepsis
6%
Quality of Life
6%
Phototherapy
6%
Virus
6%
Orthodontics
6%
Coronavirinae
6%
Diseases
6%
Surgery
5%
Hepatocellular Carcinoma
5%
Interleukin 6
5%
Birth Weight
5%
Body Weight
5%
Gestational Age
5%
Decompressive Craniectomy
5%
Messenger RNA
5%
Collagen Type 1
5%